SCHEMBL8933502

SCHEMBL8933502

C=S1C(=S)NC(=O)C1c1ccc(O)c(C(C)(C)C)c1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7748638 0.86 — —
SCHEMBL7118120 0.70 — —
SCHEMBL8933506 0.68 CA2 (0.30) —
SCHEMBL8641079 0.63 — —
SCHEMBL30027143 0.63 ALDH1A1 (0.48) —
SCHEMBL70068 0.63 ALDH1A1 (0.48) —
SCHEMBL8641630 0.61 HSD17B3 (0.34) —
SCHEMBL28420272 0.58 NUDT1 (0.41) —
SCHEMBL8933444 0.58 — —
SCHEMBL8933513 0.58 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996022772-A1 METHOD FOR TREATING MULTIPLE SCLEROSIS ELI LILLY AND COMPANY (US) 1996-08-01 — — WO disclosed
Send feedback